FDA Approves Phase II of Stem Cell Trial for ALS Led by University of Michigan's

To date, the first phase of the trial has taken place at The FDA approval of a Phase II trial was announced today by Neuralstem, the company whose product the trial is testing.

http://www.biospace.com/news_story.aspx?StoryID=293549&full=1